Trial Profile
Inuence of combined oral contraception with progestin dominancy on uterine fibroid development
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Jul 2012
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/gestodene (Primary)
- Indications Uterine leiomyoma
- Focus Therapeutic Use
- 15 Jul 2012 New trial record
- 23 Jun 2012 Results presented at the 12th Congress of the European Society of Contraception.